C A Jackevicius
Affiliation: University of Toronto
- Use of the statins in patients after acute myocardial infarction: does evidence change practice?C A Jackevicius
Pharmacy Department, University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
Arch Intern Med 161:183-8. 2001....
- Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarctionCynthia A Jackevicius
University Health Network and Department of Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Circulation 117:1028-36. 2008..Our objectives were to characterize, to determine factors of, and to measure outcomes associated with primary nonadherence after AMI...
- Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patientsCynthia A Jackevicius
University Health Network, Toronto, ON, Canada
Pharmacoepidemiol Drug Saf 16:207-15. 2007..To assess the degree of concordance between the information (drug quantity, days' supply, and daily dose) recorded on hospital discharge prescriptions and what appears in a public drug insurance electronic claims database...
- Acute treatment of myocardial infarction in Canada 1999-2002Cynthia A Jackevicius
Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario M5G 2C4
Can J Cardiol 21:145-52. 2005..Therapy for management of acute myocardial infarction (AMI) varies according to patient, prescriber and geographical characteristics...
- Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registryCynthia A Jackevicius
University Health Network, Toronto, Ontario
Can J Cardiol 21:27-32. 2005..Clinical trials have demonstrated the benefit of glycoprotein IIb/IIIa inhibitors (GPIs) with stenting in the setting of percutaneous coronary intervention (PCI) in reducing adverse cardiac outcomes...
- Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001Cynthia A Jackevicius
Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario, Canada
Can J Cardiol 19:1359-66. 2003..There is increasing interest in studying trends in drug utilization because drug costs are the fastest growing sector of the health care system...
- Adherence with statin therapy in elderly patients with and without acute coronary syndromesCynthia A Jackevicius
Department of Health Policy, Management, and Evaluation, Pharmacy Department and Women s Health Program, University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
JAMA 288:462-7. 2002..Research prior to these trials of older lipid-lowering agents demonstrated low levels of 1-year adherence...
- The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary interventionJessica M Ma
Pharmacy Department, Toronto East General Hospital, Canada
Can J Cardiol 22:419-23. 2006....
- Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgeryDoret K F Cheng
General Medicine, Mount Sinai Hospital, Toronto, Ontario
Can J Cardiol 20:223-8. 2004..Eptifibatide and tirofiban appear to have favourable safety profiles compared with abciximab in the setting of emergency or urgent CABG after failed PCI...
- Use of ezetimibe in the United States and CanadaCynthia A Jackevicius
University Health Network, Schulich Heart Centre, Toronto
N Engl J Med 358:1819-28. 2008..We sought to describe the adoption of ezetimibe relative to that of other lipid-lowering agents and compare its use in the two countries...
- Association between ACE inhibitors and acute pancreatitis in the elderlyRoger M S Cheng
Princess Margaret Hospital, Toronto, Ontario, Canada
Ann Pharmacother 37:994-8. 2003..At present, no epidemiologic studies examining the potential association between ACE inhibitors and acute pancreatitis have been identified...
- The importance of in-hospital statin therapy for patients with acute coronary syndromesFran L Paradiso-Hardy
Department of Pharmacy, Sunnybrook and Women s College Health Sciences Centre, Faculty of Pharmacy, University of Toronto, Ontario, Canada
Pharmacotherapy 23:506-13. 2003..Various strategies have been developed to aid in the implementation of in-hospital lipid-lowering therapy. Pharmacists can play a valuable role in optimizing drug therapy for dyslipidemia and ensuring long-term adherence...
- Anti-Xa monitoring of enoxaparin for acute coronary syndromes in patients with renal diseaseJessica M Ma
Department of Pharmaceutical Services, Toronto East General Hospital, Toronto, Ontario, Canada
Ann Pharmacother 38:1576-81. 2004..To account for the potentially delayed drug elimination in these patients, we developed guidelines for adjusting enoxaparin dosing based on anti-Xa monitoring...
- Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 yearsDennis T Ko
Institute for Clinical Evaluative Sciences, Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Circ Cardiovasc Interv 3:140-7. 2010..The incidence of late bleeding after PCI, its independent predictors, and its prognostic importance in clinical practice has not been fully addressed...
- Cardiovascular outcomes after a change in prescription policy for clopidogrelCynthia A Jackevicius
Western University of Health Sciences, College of Pharmacy, 309 E Second St, Pomona, CA 91766, USA
N Engl J Med 359:1802-10. 2008....
- Use of OTC and herbal products in patients with cardiovascular diseaseChantal Pharand
Faculty of Pharmacy, Université de Montréal and Hôpital du Sacré Coeur de Montréal, Montreal, Quebec, Canada
Ann Pharmacother 37:899-904. 2003..The use of nonprescription and herbal products by the public is rising, resulting in an increased potential for adverse reactions or drug interactions in cardiac patients...
- Indicators of quality of care for patients with acute myocardial infarctionJack V Tu
The Institute for Clinical Evaluative Sciences, Toronto, Ont
CMAJ 179:909-15. 2008..We undertook this initiative to develop an updated set of evidence-based indicators to measure and improve the quality of care for this patient population...